{{Rsnum
|rsid=2903308
|Chromosome=16
|position=13563028
|Orientation=plus
|GMAF=0.3526
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=LOC101927287
|Gene_s=LOC101927287
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 27.7 | 53.6 | 18.8
| HCB | 1.5 | 27.9 | 70.6
| JPT | 4.4 | 29.2 | 66.4
| YRI | 4.8 | 48.3 | 46.9
| ASW | 19.6 | 46.4 | 33.9
| CHB | 1.5 | 27.9 | 70.6
| CHD | 1.9 | 32.4 | 65.7
| GIH | 19.8 | 41.6 | 38.6
| LWK | 4.5 | 36.4 | 59.1
| MEX | 10.3 | 37.9 | 51.7
| MKK | 14.1 | 46.2 | 39.7
| TSI | 17.8 | 58.4 | 23.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22760553
  |Trait=Response to citalopram treatment
  |Title=Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
  |RiskAllele=A
  |Pval=2E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}